Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Infectious Diseases

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/423959PMID 15472849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• Pulmonary rehabilitation in chronic obstructive pulmonary disease.

  2005cited by this paper
• Clinical Management of Chronic Obstructive Pulmonary Disease

  2004cited by this paper
• COPD exacerbations: definitions and classifications

  2003cited by this paper
• Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

  2003cited by this paper
• Viral respiratory infections in elderly patients and patients with chronic obstructive pulmonary disease

  2002cited by this paper
• Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.

  2002cited by this paper
• Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions.

  2002cited by this paper
• Use of antibiotics in patients admitted to the hospital due to acute exacerbation of chronic obstructive pulmonary disease (COPD).

  2002cited by this paper
• Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

  2001cited by this paper
• Management of acute exacerbations of COPD: a summary and appraisal of published evidence.

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• The role of bacteria in exacerbations of COPD. A constructive view.

  2000cited by this paper
• Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia.

  2000cited by this paper
• Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

  2000cited by this paper
• Toward a consensus definition for COPD exacerbations.

  2000cited by this paper
• Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

  2000cited by this paper
• Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

  1999cited by this paper
• Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

  1999cited by this paper
• Pulmonary rehabilitation in chronic obstructive pulmonary disease.

  1999cited by this paper
• Clinical Investigations: Inflammation/InfectionInfective Exacerbations of Chronic Bronchitis: Relation between Bacteriologic Etiology and Lung Function

  1998cited by this paper
• Management of adult community-acquired lower respiratory tract infections

  1998cited by this paper
• Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

  1998cited by this paper
• Guidelines for management of adult community-acquired lower respiratory tract infections

  1998cited by this paper
• Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.

  1998cited by this paper
• Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.

  1996cited by this paper
• Use of investigations in lower respiratory tract infection in the community: a European survey.

  1996cited by this paper
• Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.

  1995cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations

  1995cited by this paper
• Clinical Investigations: InfectionC-Reactive Protein: A Clinical Marker in Community-Acquired Pneumonia

  1995cited by this paper
• Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

  1995cited by this paper
• Quantitative study of the bronchial bacterial flora in acute exacerbations of chronic bronchitis.

  1994cited by this paper
• Reversible airflow limitation in adults with respiratory infection.

  1994cited by this paper
• Iatrogenic aspiration. Follow-up.

  1994cited by this paper
• Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

  1992cited by this paper
• Lung function testing: selection of reference values and interpretative strategies.

  1992cited by this paper
• Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

  1991cited by this paper
• Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients.

  1990cited by this paper
• A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD.

  1989cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987influential reference

• The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

  2025cites this paper
• Sputum Color as a Marker for Bacteria in Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.

  2023cites this paper
• The importance of obtaining a sputum sample and how it can aid diagnosis and treatment.

  2019cites this paper
• Hubungan antara kadar procalcitonin dengan kriteria Anthonisen pada PPOK eksaserbasi akut

  2019cites this paper
• Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2019cites this paper
• The Relationship Between Causative Microorganisms and Airway Obstruction in Patients with COPD Exacerbation

  2019cites this paper
• Manejo integral del paciente con exacerbación aguda de la enfermedad pulmonary

  2018cites this paper
• Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care

  2017cites this paper
• Sputum colour can identify patients with neutrophilic inflammation in asthma

  2017cites this paper
• Assessment of exhaled carbon monoxide in exacerbations of chronic obstructive pulmonary disease.

  2016cites this paper
• Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2)

  2016cites this paper
• Veiligheid en verdraagbaarheid van verneveling van amoxicilline + clavulaanzuur bij stabiele coPD-pati??nten

  2015cites this paper
• Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes before and after Treatment of AECOPD, a Longitudinal and Cross-sectional Study

  2015cites this paper
• A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease.

  2014cites this paper
• Les médecins sont-ils prêts à faire confiance à la procalcitonine pour guider la mise sous antibiotiques dans l’exacerbation de BPCO ?

  2014cites this paper
• Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations

  2014cites this paper
• Caracterização do perfil dos pacientes em oxigenoterapia domiciliar em uma cidade do interior do estado de São Paulo

  2014cites this paper
• C-Reactive Protein Levels Predict Bacterial Exacerbation in Patients With Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Lung microbiology and exacerbations in COPD

  2012cites this paper
• The use of biomarkers to explore inflammation and phenotypes during exacerbations of chronic obstructive pulmonary disease

  2012cites this paper
• Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.

  2012cites this paper
• Treatment and Outcome

  2012cites this paper
• [Treatment effects of co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: clinical evaluation].

  2011cites this paper
• KLINIČKA EFIKASNOST ANTIBIOTIKA KOAMOKSIKLAVA (CO-AMOXICLAV 2X) KOD PACIJENATA HOSPITALIZOVANIH SA AKUTNIM POGORŠANJEM HRONIČNE OPSTRUKTIVNE BOLESTI PLUĆA TREATMENT EFFECTS OF CO-AMOXICLAV (AMOXICLAV 2x) IN ACUTE EXACERBATION OF SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CLINICAL EVALUATION I

  2011cites this paper
• Role of Biomarkers in Exacerbation of Chronic Obstructive Pulmonary Disease

  2011cites this paper
• Acute exacerbations of COPD: identification of biological clusters and their

  2011cites this paper
• Relation Between Amoxicillin Concentration in Sputum of COPD Patients and Length of Hospitalization

  2011cites this paper
• Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

  2011cites this paper
• Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease

  2011cites this paper
• Impact on clinical decision making of quality control standards applied to sputum analysis in COPD.

  2011cites this paper
• The appropriateness of the South African Thoracic Society’s guidelines for antibiotic treatment of patients with chronic obstructive pulmonary disease exacerbation in the Universitas Academic Hospital, Bloemfontein

  2010cites this paper
• Discriminate use of antibiotics for exacerbation of COPD

  2009cites this paper
• Relation of sputum colour to bacterial load in acute exacerbations of COPD.

  2009cites this paper
• Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease

  2009cites this paper
• Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease

  2009cites this paper
• COPD exacerbations : treatment and outcome

  2009cites this paper
• Perfil de patógenos nas exacerbações agudas da doença pulmonar obstrutiva crônica: resultados preliminares. Pathogenic profile in acute exacerbations of chronic obstructuve pulmonary disease: preliminary results.

  2009cites this paper
• Factors Predicting Bacterial Involvement in Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2008cites this paper
• Aerosolized antibiotics for ventilator-associated tracheobronchitis: let's go with the flow!

  2008cites this paper
• Is It Possible to Reduce the Use of Antibiotics in Severe Exacerbations of Chronic Obstructive Pulmonary Disease?

  2008cites this paper
• Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria

  2008cites this paper
• [Systemic markers of exacerbated chronic obstructive pulmonary disease: how they can help with the decision of whether or not to prescribe antibiotics].

  2008cites this paper
• Identification of Bacterial Infection in Patients Presenting With Acute Exacerbation of Chronic Bronchitis With Particular Reference to Clinical Trials of Antibacterial Drugs.

  2008cites this paper
• Marcadores biológicos sistémicos en las agudizaciones de la EPOC: ¿nos ayudan en la decisión de prescribir tratamiento antibiótico?

  2008cites this paper
• The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease

  2007cites this paper
• Tratamiento farmacológico de las agudizaciones infecciosas de la EPOC

  2007cites this paper
• Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.

  2007cites this paper
• Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity*

  2007cites this paper
• Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review

  2007cites this paper
• Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs.

  2007cites this paper
• New Approaches to the Laboratory Diagnosis of Legionnaires' Disease

  2007cites this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

  2006cites this paper
• Comment évaluer, orienter et suivre un patient ayant une pneumonie aiguë communautaire ? Une exacerbation de bronchopneumopathie chronique obstructive ?

  2006cites this paper
• Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome*

  2006cites this paper
• Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones

  2006cites this paper
• Clinical Year Review of COPD.

  2006cites this paper
• Chronic obstructive pulmonary disease, antibiotics, and prediction of bacterial infection.

  2005cites this paper
• Chronic obstructive pulmonary disease, antibiotics, and prediction of bacterial infection.

  2005cites this paper
• Akute Exazerbation der chronisch-obstruktiven Lungenerkrankung

  2005cites this paper
• Efficacité et tolérance de la clarithromycine, forme à libération modifiée en traitement court de cinq jours dans les exacerbations aiguës de bronchite chronique, comparativement à la télithromycine

  2005cites this paper
• [Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis].

  2005cites this paper
• Reply to De Maria

  2005cites this paper
• Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.

  2004influential citation
• Predicting Bacterial Exacerbations of COPD: Do We Care?

  2004cites this paper
• Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands.

  2004cites this paper